Funding
Turn ideas into impact
Show Me
Due: November 19, 2026
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer’s Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-226
Due: November 19, 2026
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Type
Cooperative Agreement
Source
Federal
Opp Number
PAR-25-052
Due: November 23, 2026
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
US $375,000
Type
Grant
Source
Federal
Opp Number
RFA-AT-25-003
Due: November 24, 2026
Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PA-23-317
Due: November 30, 2026
Topical Workshops, Symposiums, and Conferences (TWSC-24) in Space and Earth Sciences and Technology
Type
Cooperative Agreement
Source
Federal
Opp Number
NNH24ZDA002N
Due: December 1, 2026
National Center for Construction Safety and Health Research and Translation (U54)
US $3,000,000 – $5,750,000
Type
Cooperative Agreement
Source
Federal
Opp Number
RFA-OH-24-001
Due: December 3, 2026
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-24-296
Due: December 3, 2026
Emerging Global Leader Award (K43 Independent Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-24-295
Due: December 4, 2026
NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
Type
Grant
Source
Federal
Opp Number
RFA-OD-24-011
Do you have a grant, incentive, funding competition, or other funding source to share?